M&A Deal Summary

deCODE genetics Acquires MediChem Life Sciences

On March 18, 2002, deCODE genetics acquired life science company MediChem Life Sciences from MedEquity Capital

Acquisition Highlights
  • This is deCODE genetics’ 1st transaction in the Life Science sector.
  • This is deCODE genetics’ 1st transaction in the United States.
  • This is deCODE genetics’ 1st transaction in Illinois.

M&A Deal Summary

Date 2002-03-18
Target MediChem Life Sciences
Sector Life Science
Buyer(s) deCODE genetics
Sellers(s) MedEquity Capital
Deal Type Add-on Acquisition
Advisor(s) UBS Investment Bank (Financial)

Target

MediChem Life Sciences

Woodridge, Illinois, United States
MediChem Life Sciences, Inc. provides contract medicinal chemistry and research services to the life science industry.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

deCODE genetics

Reykjavik, Iceland

Category Company
Founded 1996
Sector Life Science
Employees331
DESCRIPTION

deCODE genetics is a population-based genomics company conducting research into the inherited causes of common diseases. Together with pharmaceutical companies and other healthcare institutions, deCODE aims to utilize its research to develop new methods for identifying, treating and preventing disease.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Illinois M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2002 M&A 1 of 1

Seller(S) 1

SELLER

MedEquity Capital

Wellesley Hills, Massachusetts, United States

Investor Investor Investor


Category Private Equity Firm
Founded 1999
Size Middle-Market
Type Sector Focused
DESCRIPTION

MedEquity Capital LLC is a specialist private equity firm that invests in mid- to late-stage healthcare service and product companies. MedEquity's focus within healthcare services includes provider based services, out-sourced non-core services, infrastructure-focused businesses, product companies with low technology risk, and technology driven service companies. MedEquity will consider both control and non-control investments and looks invest between $5 and $30 million per transaction. Investment funds are typically used to support recapitalizations, acquisitions, and growth. MedEquity Capital LLC was formed in 2002 and is based in Wellesley Hills, Massachusetts.


DEAL STATS #
Overall 1 of 9
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 8
State: Illinois M&A 1 of 1
Country: United States M&A 1 of 9
Year: 2002 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-06-06 Decision Management International

Bradenton, Florida, United States

Decision Management International, Inc. is a provider of software and associated consulting services for complexity reduction for FDA-regulated industries.

Buy $14M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2002-12-10 EnduraCare Therapy Management

Las Vegas, Nevada, United States

EnduraCare Therapy Management, Inc. provides contract therapy care to America's premier hospitals, long-term care facilities, and physician groups.

Buy -